150 related articles for article (PubMed ID: 11034964)
1. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects.
Liu S; Semenciw R; Waters C; Wen SW; Mery LS; Mao Y
Int J Epidemiol; 2000 Oct; 29(5):826-31. PubMed ID: 11034964
[TBL] [Abstract][Full Text] [Related]
2. Trends in testicular germ cell cancer incidence in Australia.
Baade P; Carrière P; Fritschi L
Cancer Causes Control; 2008 Dec; 19(10):1043-9. PubMed ID: 18478339
[TBL] [Abstract][Full Text] [Related]
3. Testicular cancer incidence in eight northern European countries: secular and recent trends.
Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775
[TBL] [Abstract][Full Text] [Related]
4. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
Weir HK; Marrett LD; Moravan V
CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441
[TBL] [Abstract][Full Text] [Related]
5. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995.
Wanderås EH; Grotmol T; Fosså SD; Tretli S
Cancer Causes Control; 1998 Oct; 9(5):475-86. PubMed ID: 9934714
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence of testicular cancer in Norway 1955-1992.
Wanderås EH; Tretli S; Fosså SD
Eur J Cancer; 1995 Nov; 31A(12):2044-8. PubMed ID: 8562163
[TBL] [Abstract][Full Text] [Related]
7. Birth cohort effects underlying the increasing testicular cancer incidence in Canada.
Liu S; Wen SW; Mao Y; Mery L; Rouleau J
Can J Public Health; 1999; 90(3):176-80. PubMed ID: 10401168
[TBL] [Abstract][Full Text] [Related]
8. Population based incidence and age distribution of spermatocytic seminoma.
Carrière P; Baade P; Fritschi L
J Urol; 2007 Jul; 178(1):125-8. PubMed ID: 17499277
[TBL] [Abstract][Full Text] [Related]
9. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes.
Richiardi L; Akre O; Bellocco R; Ekbom A
Br J Cancer; 2002 Aug; 87(5):545-50. PubMed ID: 12189554
[TBL] [Abstract][Full Text] [Related]
10. The increasing burden of testicular seminomas and non-seminomas in adolescents and young adults (AYAs): incidence, treatment, disease-specific survival and mortality trends in the Netherlands between 1989 and 2019.
van der Meer DJ; Karim-Kos HE; Elzevier HW; Dinkelman-Smit M; Kerst JM; Atema V; Lehmann V; Husson O; van der Graaf WTA
ESMO Open; 2024 Feb; 9(2):102231. PubMed ID: 38244349
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
[TBL] [Abstract][Full Text] [Related]
12. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults.
dos Santos Silva I; Swerdlow AJ; Stiller CA; Reid A
Int J Cancer; 1999 Nov; 83(5):630-4. PubMed ID: 10521799
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in the incidence of testicular germ cell tumors in the United States.
Ghazarian AA; Trabert B; Devesa SS; McGlynn KA
Andrology; 2015 Jan; 3(1):13-8. PubMed ID: 25331158
[TBL] [Abstract][Full Text] [Related]
14. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
[TBL] [Abstract][Full Text] [Related]
15. Seminoma arising in cryptorchid testes in Nigerian males.
Ogunbiyi JO; Shittu OB; Aghadiuno PU; Lawani J
East Afr Med J; 1996 Feb; 73(2):129-32. PubMed ID: 8756054
[TBL] [Abstract][Full Text] [Related]
16. Testicular cancer among US men aged 50 years and older.
Ghazarian AA; Rusner C; Trabert B; Braunlin M; McGlynn KA; Stang A
Cancer Epidemiol; 2018 Aug; 55():68-72. PubMed ID: 29807233
[TBL] [Abstract][Full Text] [Related]
17. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark.
Jacobsen R; Møller H; Thoresen SØ; Pukkala E; Kjaer SK; Johansen C
Int J Androl; 2006 Feb; 29(1):199-204. PubMed ID: 16371112
[TBL] [Abstract][Full Text] [Related]
18. Geographic clustering of testicular cancer incidence in the northern part of The Netherlands.
Sonneveld DJ; Schaapveld M; Sleijfer DT; Meerman GJ; van der Graaf WT; Sijmons RH; Koops HS; Hoekstra HJ
Br J Cancer; 1999 Dec; 81(7):1262-7. PubMed ID: 10584892
[TBL] [Abstract][Full Text] [Related]
19. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
[TBL] [Abstract][Full Text] [Related]
20. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
